BDTX (STOCKS)
Black Diamond Therapeutics, Inc. Common Stock
$2.220000
-0.060000 (-2.63%)
Prev close: $2.280000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Mark A. Velleca
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $127.89M
- Employees
- 54
- P/E (TTM)
- 6.28
- P/B (TTM)
- 1.03
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $70.00M |
| Nonoperating Income/Loss | $9.64M |
| Operating Expenses | $58.14M |
| Research and Development | $39.56M |
| Other Operating Expenses | $18.58M |
| Operating Income/Loss | $11.86M |
| Income/Loss From Continuing Operations After Tax | $21.50M |
| Income/Loss From Continuing Operations Before Tax | $54.02M |
| Net Income/Loss | $21.50M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $21.50M |
| Net Income/Loss Available To Common Stockholders, Basic | $21.50M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.38 |
| Diluted Earnings Per Share | $0.37 |
| Basic Average Shares | 57,330,089 |
| Diluted Average Shares | 58,010,846 |
| Assets | $157.73M |
| Current Assets | $138.99M |
| Noncurrent Assets | $18.74M |
| Fixed Assets | $1.13M |
| Other Non-current Assets | $17.61M |
| Liabilities | $31.58M |
| Current Liabilities | $15.55M |
| Accounts Payable | $975.00K |
| Wages | $2.37M |
| Other Current Liabilities | $12.20M |
| Noncurrent Liabilities | $16.04M |
| Equity | $126.15M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $126.15M |
| Liabilities And Equity | $157.73M |
| Net Cash Flow From Operating Activities | $21.35M |
| Net Cash Flow From Operating Activities, Continuing | $21.35M |
| Net Cash Flow From Investing Activities | -$14.25M |
| Net Cash Flow From Investing Activities, Continuing | -$14.25M |
| Net Cash Flow From Financing Activities | $341.00K |
| Net Cash Flow From Financing Activities, Continuing | $341.00K |
| Net Cash Flow | $7.44M |
| Net Cash Flow, Continuing | $7.44M |
| Comprehensive Income/Loss | $21.53M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $21.53M |
| Other Comprehensive Income/Loss | $21.53M |